ENCOD
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
November 9, 2008  |  By ENCOD In 2008

DRUG USE IN THE EU HISTORICALLY HIGH

arton1485

[European Parliament Press Release

 >http://www.europarl.europa.eu ]

06 Nov 2008

Every year 7,000-8,000 people in the EU die because of drug use and a drugs overdose remains one of the main causes of death among young people. These are some of the findings of a report by the Europe’s drug monitoring agency, released to Parliament’s Civil Liberties Committee Wednesday.

Cannabis, cocaine, amphetamines and LSD are the most commonly used drugs across Europe, the Lisbon-based European Monitoring Centre for Drugs and Drug Addiction said in its annual report.

It estimates 4 million Europeans use cannabis daily, or almost daily, while 12 million people have used cocaine at least once. In comparison 11 million Europeans have taken amphetamines and 9.5 million ecstasy.

New drugs gaining popularity

Newer drugs like BZP, GHP and Ketamine are fast emerging as drugs of choice. Another emerging drug is Fentanyl, which according to the report “is considerably more potent than heroin and its use can be particularly risky”.

Drugs in Europe

* € 60 – cost to every European of drug problem

* 36% rise in drug offences between 2001-2006

* 2/3 of cocaine seized in Europe is in the transit countries of Portugal and Spain

Unveiling the report, director of the centre Wolfgang Götz told MEPs, “although drug use levels remain historically high, we appear to be entering a more stable phase”.

“Every hour, one of our citizens’ dies”

However, he quashed any cause for optimism by telling MEPs that “every hour, one of our citizens’ dies of drug consumption”. Responding to a question from Spanish Socialist Bárbara Dührkop Dührkop about why drug prevention is not on school agendas, Mr Götz said, “there is little evidence that it helps and works”.

The agency believes identifying vulnerable groups such as early school leavers, children in care and homeless young people could be the best way forward and says targeting these groups could play a vital role in responses to drug use.

Italian Liberal Marco Cappato said that “saving people has to be in the driving seat”.

The Chair of the monitoring centre Marcel Reimen explained, “Today’s picture of a divided market suggests that, rather than focus on individual substances, we must adopt a holistic approach to stimulants.” He added, “There is a potential risk that gains made in reducing the availability of drugs could simply result in consumers switching to another.”

Heroin affects the young

Data indicates the number of heroin users is rising, with 40% of those using needles in countries like Estonia, Lithuania, Austria and Romania under 25. Thanks in part to needle sharing, HIV infections are increasing by 3,000 a year and 40% of those injecting are infected with Hepatitis C.

Treatment for opiate abuse still accounts for 80% of all drug treatments. “We need to involve Afghanistan, the biggest opium producer in the world” said Giusto Catania of the GUE/NGL group.

Parliament passed a resolution in July expressing “deep concern about the ever-expanding cultivation and trafficking of opium, which has serious political and national security implications in Afghanistan and neighbouring countries”.

Previous StoryPILLENWARNUNGEN
Next StoryPRODUCTORES DE COCA DEFIENDEN DESPENALIZACIÓN EN REUNIÓN DE ONU EN VIENA

Related Articles

  • arton1542
    LETTER TO QUEEN BEATRIX OF THE NETHERLANDS
  • arton1522
    MOROCCO OPENS THE DEBATE ON CANNABIS LEGALIZATION

Categories

Archives

  • About us
  • Downloads
  • Contact
  • Privacy Policy
  • Legal Notice & Terms of Use
  • Imprint

Copyright ©2018 ThemeFuse. All Rights Reserved

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT

REPUBLISHING TERMS

You may republish this article online or in print under our Creative Commons license. You may not edit or shorten the text, you must attribute the article to ENCOD and you must include the author’s name in your republication.

If you have any questions, please email thujer@gmail.com

License

Creative Commons License AttributionCreative Commons Attribution
DRUG USE IN THE EU HISTORICALLY HIGH